Skip to main content
Clinical Trials/NL-OMON33679
NL-OMON33679CompletedNot Applicable

Pre-operative CT to improve delineation of the tumorbed in radiotherapy for breast cancer. - Delineation of the tumorbed in breast cancer.

MAASTRO clinic0 sites60 target enrollmentStarted: TBDLast updated:
Conditions

Trial Snapshot

Phase
Not Applicable
Status
Completed
Enrollment
60

Study Overview

Brief Summary

No summary available.

Study Design

Study Type
Observational

Eligibility Criteria

Ages
18 to 99 (—)

Inclusion Criteria

  • Female patients with proven breast cancer, to be treated with breast conserving therapy, and a visible mass on mammography or ultrasound > 0.5 cm.

Exclusion Criteria

  • * All contra-indications for breast conserving therapy, i.e. pregnancy, multicentricity, inoperable disease, or a too large tumor in a relatively too small breast.
  • * All contra-indications for intravenous contrast, i.e. iodine allergy, renal malfunction (kreatinine clearance < 60 ml/min), , previous allergic reaction to i.v. contrast, M. Kahler, use of NSAIDs, Diuretics or Metformine.
  • * Absence of tumor mass > 0.5 cm on mammography or ultrasound.

Investigators

Similar Trials